Boehringer Ingelheim has landed an exclusive license to Prime Vector Technologies’ (PVT) viral vector platform for developing ...

In 2024, the Colorado Prescription Drug Affordability Review Board declared Enbrel unaffordable, and last year it set an ...

Amgen (AMGN) closed at $366.44 in the latest trading session, marking a -2.06% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.72%. Elsewhere, the Dow gained 0.

Healthcare stocks are attractive in a choppy market. These funds, focusing on the broader sector, drugmakers, and biotechs, ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

Hope has been expressed that the focus of September’s high-profile golf tournament in Doonbeg will be on the sport rather than the resort’s owner. It comes after US President Donald Trump expressed ...

Amgen has issued a voluntary recall for nearly 1 million bottles of the heart medication Corlanor (ivabradine) due to possible contamination. The nationwide recall was issued by the company on June 4 ...

Alphabet may be the Dow's newest member, but these three dividend-paying Dow stocks look like the better buys for income ...

Over 900,000 bottles of heart and kidney medications are being recalled from retailers nationwide due to possible ...

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.

Testing that raised concerns about possible foreign contamination has triggered a recall in the United States of nearly 1 ...

A U.S. Centers for Medicare & Medicaid Services 18-month ​trial program will offer for the first time Novo Nordisk’s Wegovy ...